Schioth HB, Craft S, Brooks SJ, Frey WH II, Benedict C
PubMed abstract Low Socioeconomic Status is Associated with Increased Risk for Hypoglycemia in Diabetes Patients: The Diabetes Study of Northern California (DISTANCE) Authors: Berkowitz SA
Manu Chakravarthy, vice president at Genentech, said, Amylin helps people feel satisfied after a meal, but it doesn't make them feel like they don't want to eat at all, calling it a subtle but important difference. James List, head of internal medicine research at Pfizer, who is conducting research on amylin, said, If there is clinical differentiation, we can fill unmet gaps in the obesity drug market, adding, Even if we enter the market later, it is necessary to develop a differentiated product. Eli Lilly and Novo Nordisk, which already dominate the market, have also begun developing amylin-based therapies
Many patients find BPC-157 therapy cost-effective compared to prolonged physical therapy, multiple specialist visits, or the indirect costs of chronic pain and disability.
source: Policosanol 60% Policosanol seems to decrease cholesterol production in the liver and to increase the breakdown of LDL (low-density lipoprotein or bad) cholesterol